share_log

OKYO Pharma | 4/A: Statement of changes in beneficial ownership of securities (and amendment thereto)-Officer CERRONE GABRIELE M

SEC ·  May 18, 2022 13:38
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more